Trial
NCT01431534
A Study of Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-056)
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Merck Sharp & Dohme LLC
Collaborators
—
Condition
Solid Tumors
Intervention
Ridaforolimus
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-03-01